Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Tormey

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Transfusion|December 2, 2008
The persistence and evanescence of blood group alloantibodies in menChristopher A Tormey, Gary Stack
Blood|August 29, 2009
Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodiesChristopher A Tormey, Gary Stack
Transfusion|August 18, 2009
The characterization and classification of concurrent blood group antibodiesChristopher A Tormey, Gary Stack
Archives of Pathology & Laboratory Medicine|October 31, 2014
Use of a cytokine-release assay to demonstrate loss of platelet secretory capacity during blood bank processing and storageChristopher A Tormey, Gary Stack
Blood|October 15, 2014
Abnormal lymphocytes with "filamentous-like" cytoplasmic inclusions in chronic lymphocytic leukemiaRichard Torres, Christopher A Tormey
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 15, 2022
Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?Juan Vitelio Rodriguez, Christopher A Tormey
Vaccine|August 25, 2016
Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typingJeanne E Hendrickson, Christopher A Tormey
Transfusion|December 12, 2012
The transfusion medicine specialist as a coagulation consultant: a new variant of therapeutic pathologyChristopher A Tormey, Brian R Smith
Military Medicine|October 1, 2014
The development and implementation of, and first years' experience with, a massive/emergency transfusion protocol (damage control hematology protocol) in a Veterans Affairs hospitalEric A Gehrie, Christopher A Tormey
Archives of Pathology & Laboratory Medicine|December 1, 2015
Edoxaban: Efficacy, Laboratory Monitoring, and Approach to ReversalEric A Gehrie, Christopher A Tormey
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Transfusion|December 2, 2008
The persistence and evanescence of blood group alloantibodies in menChristopher A Tormey, Gary Stack
Blood|August 29, 2009
Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodiesChristopher A Tormey, Gary Stack
Transfusion|August 18, 2009
The characterization and classification of concurrent blood group antibodiesChristopher A Tormey, Gary Stack
Archives of Pathology & Laboratory Medicine|October 31, 2014
Use of a cytokine-release assay to demonstrate loss of platelet secretory capacity during blood bank processing and storageChristopher A Tormey, Gary Stack
Blood|October 15, 2014
Abnormal lymphocytes with "filamentous-like" cytoplasmic inclusions in chronic lymphocytic leukemiaRichard Torres, Christopher A Tormey
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 15, 2022
Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone?Juan Vitelio Rodriguez, Christopher A Tormey
Vaccine|August 25, 2016
Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typingJeanne E Hendrickson, Christopher A Tormey
Transfusion|December 12, 2012
The transfusion medicine specialist as a coagulation consultant: a new variant of therapeutic pathologyChristopher A Tormey, Brian R Smith
Military Medicine|October 1, 2014
The development and implementation of, and first years' experience with, a massive/emergency transfusion protocol (damage control hematology protocol) in a Veterans Affairs hospitalEric A Gehrie, Christopher A Tormey
Archives of Pathology & Laboratory Medicine|December 1, 2015
Edoxaban: Efficacy, Laboratory Monitoring, and Approach to ReversalEric A Gehrie, Christopher A Tormey
Pageof 17